The company's sustainability programme was evaluated on its policies, actions put in place to support objectives and targets, as well as results that were generated from the programme
The new devices company will scale up its teams to create a world-class R&D centre for medical devices in India
The company does not expect the outcome of this inspection to impact its plans
The company will leverage existing hospital and clinic partners’ infrastructure to build specialised `Experience Centres’ and facilitate a seamless, end-to-end secondary care surgery delivery. It will also offer healthcare financing
saRNA is a new platform for the development of medicines and vaccines which uses similar technology to mRNA but with the added ability to self-amplify, thereby expressing proteins for longer, resulting in higher protein levels per dose level
The consultations are virtual and they have launched the Diabetes Reversal Programme to address the issue
The investment programme is expected to significantly reduce commercialisation lead times, costs and introduce more sustainable manufacturing processes
New Gibco AAV-MAX Helper Free AAV Production System helps reduce production costs and streamline the transition from research to clinical environments
Eka Care will provide a six-month complimentary trial period to all members who register before December 31, 2021
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
